Atnaujinta: 2024.11.27 11:36 (GMT+2)

Tallinna Farmaatsiatehas: Balance sheet, as at 31.03.2001

2001.05.11, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
BALANCE SHEET

BALANCE SHEET, AS AT 31.03.2001

Consolidated/unaudited
in thousand EEK 31.12.2000 31.03.2001

A S S E T S

CURRENT ASSETS
Cash and bank accounts 715 49
Customer receivables
ACCOUNTS RECEIVABLE 4,979 2,079
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERVE - -
Total 4,979 2,079
Other receivables
RECEIVABLES FROM PARENT COMPANY 30,375 33,896
OTHER SHORT-TERM RECEIVABLES 98 148
Total 30,473 30,043

Accrued income 37 37

Prepaid expenses 582 595

Inventories
RAW MATERIAL 12,134 10,844
WORK-IN-PROGRESS 565 969
FINISHED GOODS 11,654 15,176
PREPAYMENTS TO SUPPLIERS 1,331 2,113
Total 25,684 29,101

TOTAL CURRENT ASSETS 62,471 65,904

NON-CURRENT ASSETS

Long-term investments 449 449

Fixed assets
FIXED ASSETS IN NET BOOK VALUE 33,636 32,650
CONSTRUCTION IN PROGRESS 119 119
Total 33,755 32,769

Intangible assets 3,216 3,275

TOTAL NON-CURRENT ASSETS 37,420 36,493

TOTAL ASSETS 99,891 102,398


LIABILITIES AND SHAREHOLDERS’ EQUITY

LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 7,703 6,372
SHORT-TERM BANK LOANS 496 377
Total 8,200 6,749

Customers prepayments - -
Accounts payable 13,714 14,688
Other payables 3,882 2,944
Taxes payable 701 862

Accrued expenses 2,364 1,913

TOTAL CURRENT LIABILITIES 28,860 27,156

NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 24,055 24,055
PAYABLES TO PARENT COMPANY 24,351 24,351

TOTAL NON-CURRENT LIABILITIES 48,406 48,406

TOTAL LIABILITIES 77,266 75,562

SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12,500 12,500
RESERVES 2,316 2,316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2,779 7,808
PROFIT (LOSS) FOR FINANCIAL YEAR 10,587 4,211
SHAREHOLDERS’ EQUITY TOTAL 22,625 26,836

LIABILITIES AND SHAREHOLDERS’ EQUITY 99,891 102,398


Raivo Unt
Financial Director
+372 612 0201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai